IMARC Group’s report titled “Peripheral Artery Disease Market Report by Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories), End User (Hospitals, Specialty Clinics, and Others), and Region 2024-2032”. offers a comprehensive analysis of the industry, which comprises insights on the global peripheral artery disease market share. The global market size reached US$ 4.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.
Grab a sample PDF of this report: https://www.imarcgroup.com/peripheral-artery-disease-market/requestsample
Factors Affecting the Growth of the Peripheral Artery Disease Industry:
- Aging Population:
PAD is more common in older adults. As the global population ages, the number of individuals at risk for PAD rises, leading to a higher prevalence of the disease. This increases the demand for diagnostic and therapeutic interventions. Older adults are more likely to have risk factors associated with PAD, such as hypertension, high cholesterol, diabetes, and a history of smoking. The cumulative effect of these risk factors over time contributes to the higher incidence of PAD in this age group.
- Rising Incidence of Diabetes and Hypertension:
Both diabetes and hypertension are major risk factors for PAD. The rising global incidence of these conditions directly correlates with an increased number of PAD cases. Patients with diabetes and hypertension have a higher likelihood of developing PAD due to vascular complications associated with these diseases. Diabetes and hypertension contribute to the damage of blood vessels, leading to atherosclerosis, a condition characterized by the buildup of plaque in the arteries. This vascular damage is a primary cause of PAD.
- Lifestyle Changes:
Modern lifestyles often involve prolonged periods of inactivity, such as sitting for long hours at work or engaging in minimal physical activity. This sedentary behavior is a risk factor for PAD, as it contributes to poor circulation, obesity, and other health issues that increase the likelihood of developing PAD. Diets high in saturated fats, trans fats, cholesterol, and sodium contribute to the development of atherosclerosis, a condition that leads to the narrowing and hardening of arteries. This is a primary cause of PAD. The widespread consumption of unhealthy foods drives the prevalence of PAD.
Leading Companies Operating in the Peripheral Artery Disease Industry:
- Abbott Laboratories
- AngioDynamics
- B. Braun Melsungen AG
- Becton Dickinson and Company
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cardinal Health Inc.
- Cook Medical LLC
- Koninklijke Philips N.V.
- Medtronic plc
- Terumo Corporation
Peripheral Artery Disease Market Report Segmentation:
By Type:
- Peripheral Angioplasty Balloons
- Peripheral Stents
- Peripheral Catheters
- Inferior Vena Cava (IVC) Filters
- Plaque Modification Devices
- Hemodynamic Flow Alteration Devices
- Peripheral Accessories
Peripheral stents represent the largest segment. Peripheral stents are widely used for treating arterial blockages in PAD patients, offering effective vascular support and durability compared to other treatment options.
By End User:
- Hospitals
- Specialty Clinics
- Others
Based on the end-user, the market has been divided into hospitals, specialty clinics, and others.
Regional Insights:
- North America (the United States and Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others)
- Europe (Germany, France, the United Kingdom, Italy, Spain, and others)
- Latin America (Brazil, Mexico, and others); the Middle East; and Africa.
North America enjoys the leading position due to high healthcare expenditure, advanced medical infrastructure, extensive adoption of innovative PAD treatments, and a growing elderly population prone to PAD-related conditions.
Global Peripheral Artery Disease Market Trends:
Ongoing innovations in medical devices, such as drug-eluting stents and minimally invasive procedures, are enhancing treatment efficacy and patient outcomes in PAD management. The increasing elderly demographic globally is contributing to higher prevalence rates of PAD, driving the demand for diagnostic and therapeutic solutions. There is a growing emphasis on early detection and prevention strategies for PAD, including lifestyle interventions and screening programs, aimed at reducing disease progression. Developing regions are witnessing increased awareness, improved healthcare infrastructure, and rising disposable incomes, leading to greater access to PAD treatments and expanding market opportunities.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145 | United Kingdom: +44–753–713–2163